Intelligent Bio Solutions Inc
NASDAQ:INBS

Watchlist Manager
Intelligent Bio Solutions Inc Logo
Intelligent Bio Solutions Inc
NASDAQ:INBS
Watchlist
Price: 13.81 USD -5.41%
Market Cap: 13.3m USD

Operating Margin

-317%
Current
Improving
by 206.8%
vs 3-y average of -523.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-317%
=
Operating Income
$-10.4m
/
Revenue
$3.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-317%
=
Operating Income
$-10.4m
/
Revenue
$3.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Intelligent Bio Solutions Inc
NASDAQ:INBS
12.6m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
210.6B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
126.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58B USD
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37B USD
Loading...
No Stocks Found

Market Distribution

Lower than 90% of companies in the United States of America
Percentile
10th
Based on 14 112 companies
10th percentile
-317%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Intelligent Bio Solutions Inc
Glance View

Market Cap
13.3m USD
Industry
Health Care

GBS, Inc. operates as a biosensor diagnostic technology company. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2020-12-23. The firm is developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. The firm's Intelligent Bio Solutions is a biosensor platform, which is engaged in developing and launching diagnostic tests urgently needed to help people living with chronic diseases. The firm's subsidiary Intelligent Fingerprinting is engaged in the advancement of portable drugs of abuse testing through the analysis of fingerprint sweat. The test is non-invasive, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The firm also offers laboratory confirmation services. The system has applications within many sectors in safety-critical industries such as construction, transport and logistics firms, drug treatment organizations, as well as the United Kingdom (UK) coroners.

INBS Intrinsic Value
86.2 USD
Undervaluation 84%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-317%
=
Operating Income
$-10.4m
/
Revenue
$3.3m
What is Intelligent Bio Solutions Inc's current Operating Margin?

The current Operating Margin for Intelligent Bio Solutions Inc is -317%, which is above its 3-year median of -523.9%.

How has Operating Margin changed over time?

Over the last 3 years, Intelligent Bio Solutions Inc’s Operating Margin has increased from -1 856.3% to -317%. During this period, it reached a low of -1 856.3% on Sep 30, 2022 and a high of -317% on Sep 30, 2025.

Back to Top